United Kingdom Daily Briefing

BHP fell 4.64% to $84.80 and Rio Tinto dropped 2.19% to $109.59, with the Mining sector shedding 3.42% on the session — the worst performer by a wide margin. The catalyst reads as renewed concern over Chinese steel demand after soft May activity data out of Beijing; iron ore futures tracked lower in tandem. For next week, watch whether BHP holds the $83 support zone — a break there opens a retest of the February lows and puts further pressure on the FTSE 100's commodity pillar.

AstraZeneca lost $2.76 to close at $184.96, contributing meaningfully to Pharma's 0.76% sector decline and amplifying the index-level weakness given AZN's outsized FTSE 100 weighting. No single earnings catalyst is evident today, suggesting the move is macro-driven — USD strength and risk-off rotation out of high-multiple defensive growth. The stock is now down from its recent highs and the next meaningful level to watch is $182; a close below that would signal institutional distribution rather than a one-day shakeout.

British American Tobacco's ADR (BTI) was the session's standout gainer, adding 2.07% to $66.70 — the strongest move in the top-five universe today. The bid into BTI fits a classic late-week risk-off rotation: high yield, low beta, and recession-resistant cash flows attract capital when miners and pharma sell off simultaneously. If the macro tone stays cautious into next week, BTI and NGG (up 0.52% today) are the two names most likely to see continued institutional accumulation as yield-seeking capital repositions.